Results 131 to 140 of about 662,207 (147)
Some of the next articles are maybe not open access.

Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor

Journal of Diabetes, 2022
Linong Ji, Qian Ren, Linong Ji
exaly  

Discovery of remogliflozin etabonate: A potent and highly selective SGLT2 inhibitor

Bioorganic and Medicinal Chemistry, 2021
Isao Azumaya   +2 more
exaly  

Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension

Journal of Personalized Medicine, 2022
Bin-Nan Wu, Shih-Jie Jhuo
exaly  

Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria

Acta Pharmaceutica Sinica B, 2023
Xiaokang Li, Jian Li, Chao Zhang
exaly  

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection.

JACC Basic To Translational Science, 2020
Vance B Matthews, Lakshini Herat
exaly  

A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery

AACE Clinical Case Reports, 2021
Deborah Osafehinti
exaly  

A case in which SGLT2 inhibitor is a contributing factor to takotsubo cardiomyopathy and heart failure

Journal of Cardiology Cases, 2020
Haruyuki Kinoshita   +2 more
exaly  

Discovery of Ipragliflozin (ASP1941): A novel -glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus

Bioorganic and Medicinal Chemistry, 2012
Masayuki Yokota   +2 more
exaly  

SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis

Clinical Therapeutics, 2016
Ronald M Goldenberg   +2 more
exaly  

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor

New England Journal of Medicine, 2017
Michael Fralick   +2 more
exaly  
sglt2 inhibitors
type 2 diabetes mellitus
diabetes mellitus
diabetic ketoacidosis
medicine
heart failure
sodium-glucose transporter 2 inhibitors
urinary tract infection
glomerular filtration rate
previous   12  13  14  15  

Home - About - Disclaimer - Privacy